 Tumor Burden
"Tumor Burden" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The total amount (cell number, weight, size or volume) of tumor cells or tissue in the body.
| Descriptor ID |
D047368
|
| MeSH Number(s) |
E05.041.124.892
|
| Concept/Terms |
Tumor Burden- Tumor Burden
- Burden, Tumor
- Tumor Load
- Load, Tumor
- Loads, Tumor
- Tumor Loads
Tumor Weight- Tumor Weight
- Tumor Weights
- Weight, Tumor
- Weights, Tumor
|
Below are MeSH descriptors whose meaning is more general than "Tumor Burden".
Below are MeSH descriptors whose meaning is more specific than "Tumor Burden".
This graph shows the total number of publications written about "Tumor Burden" by people in this website by year, and whether "Tumor Burden" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 | | 2005 | 0 | 3 | 3 | | 2007 | 0 | 1 | 1 | | 2008 | 0 | 1 | 1 | | 2009 | 0 | 5 | 5 | | 2010 | 1 | 6 | 7 | | 2011 | 1 | 8 | 9 | | 2012 | 1 | 6 | 7 | | 2013 | 0 | 11 | 11 | | 2014 | 2 | 15 | 17 | | 2015 | 1 | 14 | 15 | | 2016 | 2 | 22 | 24 | | 2017 | 1 | 12 | 13 | | 2018 | 0 | 10 | 10 | | 2019 | 0 | 9 | 9 | | 2020 | 0 | 13 | 13 | | 2021 | 0 | 9 | 9 | | 2022 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Tumor Burden" by people in Profiles.
-
Ghaffari Laleh N, Loeffler CML, Grajek J, Stanková K, Pearson AT, Muti HS, Trautwein C, Enderling H, Poleszczuk J, Kather JN. Classical mathematical models for prediction of response to chemotherapy and immunotherapy. PLoS Comput Biol. 2022 02; 18(2):e1009822.
-
Buocikova V, Longhin EM, Pilalis E, Mastrokalou C, Miklikova S, Cihova M, Poturnayova A, Mackova K, Babelova A, Trnkova L, El Yamani N, Zheng C, Rios-Mondragon I, Labudova M, Csaderova L, Kuracinova KM, Makovicky P, Kucerova L, Matuskova M, Cimpan MR, Dusinska M, Babal P, Chatziioannou A, Gabelova A, Rundén-Pran E, Smolkova B. Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models. Biomed Pharmacother. 2022 Mar; 147:112662.
-
Sudo H, Tsuji AB, Sugyo A, Harada Y, Nagayama S, Katagiri T, Nakamura Y, Higashi T. FZD10-targeted a-radioimmunotherapy with 225 Ac-labeled OTSA101 achieves complete remission in a synovial sarcoma model. Cancer Sci. 2022 Feb; 113(2):721-732.
-
Bi J, Khan A, Tang J, Armando AM, Wu S, Zhang W, Gimple RC, Reed A, Jing H, Koga T, Wong IT, Gu Y, Miki S, Yang H, Prager B, Curtis EJ, Wainwright DA, Furnari FB, Rich JN, Cloughesy TF, Kornblum HI, Quehenberger O, Rzhetsky A, Cravatt BF, Mischel PS. Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug. Cell Rep. 2021 11 02; 37(5):109957.
-
Wu J, Galvan KJ, Bogard RD, Peterson CE, Shergill A, Crowe DL. DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer. Anticancer Res. 2021 Nov; 41(11):5393-5403.
-
Momin S, Lei Y, Tian Z, Wang T, Roper J, Kesarwala AH, Higgins K, Bradley JD, Liu T, Yang X. Lung tumor segmentation in 4D CT images using motion convolutional neural networks. Med Phys. 2021 Nov; 48(11):7141-7153.
-
Holoubek SA, MacKinney EC, Khokar AM, Kuchta KM, Winchester DJ, Prinz RA, Moo-Young TA. Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm. Surgery. 2022 01; 171(1):203-211.
-
Pineda FD. Editorial for "Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer". J Magn Reson Imaging. 2021 07; 54(1):261-262.
-
Alva AS, Mangat PK, Garrett-Mayer E, Halabi S, Hansra D, Calfa CJ, Khalil MF, Ahn ER, Cannon TL, Crilley P, Fisher JG, Haslem DS, Shrestha S, Antonelli KR, Butler NL, Warren SL, Rygiel AL, Ranasinghe S, Bruinooge SS, Schilsky RL. Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. J Clin Oncol. 2021 08 01; 39(22):2443-2451.
-
Asghar AM, McIntosh AG, Smith ZL, Kocher NJ, Lee Z, Barashi NN, Li T, Raman JD, Eggener SE, Uzzo RG, Kutikov A. Pathological characteristics of the large renal mass: potential implication for clinical role of renal biopsy. Can J Urol. 2021 04; 28(2):10620-10624.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|